Baird Initiates Coverage of Regenxbio (RGNX) with Outperform Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on June 2, 2023, Baird initiated coverage of Regenxbio (NASDAQ:RGNX) with a Outperform recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1482718366-621d9fc110c643b2b6168b07f01f697c.jpg "<div>Cost of Capital vs. Discount Rate: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-494328561-5ac238f304d1cf0037b9ee48.jpg "Market Cycles: The Key to Maximum Returns")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-13550670851-701f649a0c7d4c7faed160daacd5962b.jpg "Reverse Mortgages and Irrevocable Trusts")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-157618162-6cd029d7848249f7bacfb26614bdc95e-ffbb0c68e98f4739b58b7f802bd3fcf6.jpg "Naming a Trust as Beneficiary of a Retirement Account: Pros and Cons")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1522425794-ba638eafd6c44a47898fdf00aaa01e13.jpg "Private Equity is Coming for Your 401(K): How To Protect Yourself")